Hepatotoxicity and Associated Risk Factors in Hiv-Infected Patients Receiving Antiretroviral Therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia
Authors:
Open Access
- 11 November 2013
- journal article
- Published by African Journals Online (AJOL) in Ethiopian Journal of Health Sciences
- Vol. 23 (3) , 217-226-26
Abstract
Background: In Human Immunodeficiency Virus (HIV) infected patients on antiretroviral treatment (ART), hepatotoxicity is life threatening. Its outcome may lead to liver failure and death. This study was conducted to determine the rate and determinants of elevated alanine amino transferase (ALT) (referred as >40IU/L for both males and females). Methods: A cross sectional study was conducted on HIV infected individuals who are on ART and suspected of drug resistance at Felege Hiwot Referral Hospital, Bahir Dar from July to December 2012. Venous bloods were collected from each patient and processed parallely to determine ALT, number of HIV RNAs, CD4 and CD8 T cells count, anti hepatitis C virus (HCV) and hepatitis B surface antigen. Results: Out of 269 HIV infected patients receiving ART, 32% were confirmed of grades 1-4 levels of elevated ALT. The rate of severe hepatotoxicity (grade 3 and 4) was 1.84%. Patients with increased CD8 T cell counts (P=0.011; AOR=1.82; CI: 1.12 - 2.54), alcohol over use (P=0.014; AOR = 1.23; CI: 1.36- 3.29) and detectable HIV-1 RNA copies (P=0.015; AOR=2.07; CI: 1.15-3.74) independently predicts the elevation of ALT. Conclusions: In HIV infected patients on ART, extreme elevations of ALT were infrequent but minor elevations were common so that patient-linked variables such as use of alcohol intake must be taken in to account for better clinical management of ART patients. The role of active HCV co-infection on the treatment outcome of ART should be further studied. Key words: ALT, HIV, ART, Bahir Dar, EthiopiaKeywords
This publication has 23 references indexed in Scilit:
- Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in NigeriaBMC Clinical Pharmacology, 2012
- Effects of paliperidone extended release on the symptoms and functioning of schizophreniaBMC Clinical Pharmacology, 2012
- The association of HIV viral load with indirect markers of liver injuryJournal of Viral Hepatitis, 2011
- Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected PatientsAIDS Research and Treatment, 2010
- Nevirapine-Associated Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in a Primary Care ART Programme in South AfricaPLOS ONE, 2010
- Prevalence and Factors Associated With Liver Test Abnormalities Among Human Immunodeficiency Virus–Infected PersonsClinical Gastroenterology and Hepatology, 2010
- Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative PatientsPLOS ONE, 2008
- Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis BAIDS, 2007
- Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001AIDS, 2003
- Risk Factors for Hepatotoxicity in HIV-1--Infected Patients Receiving Ritonavir and Saquinavir with or without StavudineClinical Infectious Diseases, 2000